Lobbying client

MASSMEDIC

Medical device manufacturer

Filings
22
Filed by
1
Reported in-house
—
Reported by firms
$420,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2021 to 2026

Filings

22 filings, newest first.
Filing Filed by Amount
1st Quarter - Report
1st Quarter 2024
ML STRATEGIES, LLC $20,000 reported
4th Quarter - Report
4th Quarter 2023
ML STRATEGIES, LLC $20,000 reported
3rd Quarter - Report
3rd Quarter 2023
ML STRATEGIES, LLC $20,000 reported
2nd Quarter - Report
2nd Quarter 2023
ML STRATEGIES, LLC $20,000 reported
1st Quarter - Report
1st Quarter 2023
ML STRATEGIES, LLC $20,000 reported
4th Quarter - Report
4th Quarter 2022
ML STRATEGIES, LLC $20,000 reported
3rd Quarter - Report
3rd Quarter 2022
ML STRATEGIES, LLC $20,000 reported
2nd Quarter - Report
2nd Quarter 2022
ML STRATEGIES, LLC $20,000 reported
1st Quarter - Report (No Activity)
1st Quarter 2022
ML STRATEGIES, LLC $20,000 reported
4th Quarter - Report (No Activity)
4th Quarter 2021
ML STRATEGIES, LLC $20,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
ML STRATEGIES, LLC 21 $420,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 19

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 1691 118th 6
H.R. 1691 119th 2
H.R. 5343 119th 2

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.